Company behavioral profile
Atlas Diagnostics ATDX
In Vitro Diagnostics · Health Care · NASDAQ · S&P 500 constituent
Coverage: FY21 Q1 → FY24 Q1 · 13 calls tracked
Drifting
Management behavioral trend · last 4 quarters
This management team's language has been moving steadily away from its own historical baseline since FY23, culminating in a high-conviction Bearish Lean on the most recent call.
3.8 / 10
Avg Call Weirdness Index (peer median 2.9)
1 / 13
Calls with a Bearish Lean (peer median 0.4)
4
Calls flagged above 6.0 on either speaker
2
Descriptor-downgrade events vs same-quarter prior years
Deviation timeline · per-speaker Call Weirdness Index by quarter
Each point is one call. Click any point to open that call. Bearish-Lean quarters are highlighted.
CEO · ReinhardtCFO · Coleman
The FY24 Q1 call (rightmost) is the highest-deviation print in this team's tracked history — CFO Coleman scored a 9.1 against her own 12-call baseline.
Same-quarter Boilerplate Drift · 4 years
Reinhardt's recurring Q1 opening template, with its descriptor slot tracked annually.
Q1 FY2021
“we delivered another quarter of outstanding financial performance”
Q1 FY2022
“we delivered another quarter of excellent financial performance”
Q1 FY2023
“we delivered another quarter of very strong financial performance”
Q1 FY2024
“we delivered another quarter of solid financial performance”
Three consecutive downgrade steps — outstanding → excellent → very strong → solid — across four years of the identical opening boilerplate. Each rung is still positive language in isolation; the slope is the signal.
Q1 guidance posture · 4-year trajectory
The verb attached to full-year guidance at each Q1 review.
Q1 FY2021
raised
Q1 FY2022
meaningfully raised
Q1 FY2023
maintained
Q1 FY2024
maintained ambitious
“Maintained ambitious” is the softest Q1 guidance posture across this team's four-year track record. The “ambitious” qualifier has never been used by this CEO at a Q1 guidance review in our coverage window.
Speaker roster · tracked executives
Current13 calls
David Reinhardt
Chairman, President & CEO · since FY21 Q1
Career avg weirdness3.6
View executive profile →
Current13 calls
Sarah Coleman
SVP & CFO · since FY21 Q1
Career avg weirdness3.9
View executive profile →
Former6 calls
Margaret Voss
COO · FY21 Q1 – FY22 Q2 (departed)
Career avg weirdness2.7
Baseline retained · no longer on calls
Top recurring novel phrases at this company
Phrases this team has introduced over the past four years. Click a phrase to open the call where it first appeared.
“appropriately ambitious” — Reinhardt · forward guidance
above thresholdFY24 Q1 →
“different from the way we planned” — Coleman · guidance cadence
above thresholdFY24 Q1 →
“no net change overall” — Coleman · guidance maintenance
above thresholdFY24 Q1 →
“back-half loaded” — Coleman · first used FY23 Q4
novelFY23 Q4 →
“evolving demand signals” — Reinhardt · segment commentary
novelFY24 Q1 →
“normalization of ordering patterns” — Coleman · first used FY23 Q2
novelFY23 Q2 →
Sector peer comparison · diagnostics
How Atlas's behavioral baselines compare to four diagnostics peers. Higher = more deviation-prone.
| Company | Hedge density (avg σ) | Novel-phrase rate / call | Descriptor downgrade freq. |
|---|---|---|---|
| Atlas Diagnostics ATDX | +1.9σ | 4.2 | 0.31 |
| Helix Bioscience HLXB | +0.7σ | 2.1 | 0.12 |
| Meridian LabWorks MRLW | +0.9σ | 2.6 | 0.08 |
| Corvus Diagnostics CVDX | +1.1σ | 2.9 | 0.15 |
| Peer median | +0.9σ | 2.6 | 0.12 |
Atlas sits roughly 2× the peer median on every behavioral baseline. A team this deviation-prone produces more flagged calls per year — and warrants tighter monitoring around each print.
13
Calls tracked
13
Quarters covered
3
Executives baselined
12
Median baseline depth / speaker
Track any company's management team.
Spoken Alpha maintains per-speaker behavioral baselines across 12,408 executivesat S&P 1500 companies. Watch a team drift from itself, quarter over quarter, before the print confirms it.